The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients

Clinical Hemorheology and Microcirculation

Volumn 31, Issue 4, 2004, Pages 251-256

  Muravyov, Alexei V ^a   Yakusevich, Vladimir V ^b   Surovaya, Larisa ^b   Petrochenko, Aleksandr ^b  

^a Department of Medicine and Biology   (Russian Federation)

^b Medical Academy   (Russian Federation)

Author keywords

Aggregation; Blood; Deformability of RBC; Plasma lipids; Plasma viscosity; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; LIPID;

ADULT; ARTICLE; BLOOD DISEASE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CELL AGGREGATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL RESEARCH; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DRUG EFFECT; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMATOCRIT; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CLINICAL TRIAL; CORONARY ARTERY DISEASE; MIDDLE AGED;

BLOOD VISCOSITY; CORONARY DISEASE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMATOCRIT; HEMORHEOLOGY; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MIDDLE AGED; SIMVASTATIN;

EID: 21244483036     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. T. Pedersen, Kjekshusj, K. Berg et al., Baseline serum cholesterol and treatment effect in the Scandinavium Simvastatin Survival Study, Lancet 345 (1995), 1274-1275.
2. C. Prentice, Platelets and atherosclerosis, Eur. Heart Journal (Suppl. A) (1999), A3-A7.
3. O. Fargeman, Unresolved issues: unanswered questions, Eur. Heart Journal 1 (Suppl. J) (1999), J12-J18.
4. Y. Horsmans, Differential metabolism of statins: importance in drug-drug interactions, Eur. Heart Journal 1 (Suppl. T) (1999), T7-T12.
5. Y. Levy, R. Leibowitz, M. Aviram, J.G. Brook and U. Cogan, Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolemia, Br. J. Clin. Pharmacol. 34 (1992), 427-430.
6. M. Aviram, O. Hussein, M. Rosenblat et al., Interactions of platelets, macrophages and lipoproteins in hypercholesterolemia; antiatherogenic effects of HMG-CoA reductase inhibitor therapy, J. Cardiovasc. Pharmacol. 31 (1998), 39-45.
7. C. Cimminiello and V. Toschi, Atherothrombosis: the role of platelets, Eur. Heart Journal 1 (Suppl. A) (1999), A8-A13.
8. G. Nenci, Unifying concept of arterial vascular disease, Eur. Heart Journal 1 (Suppl. A) (1999), A27-A30.
9. J. Shepherd, S. Cobbe, I. Ford et al., Prevention of coronary heard disease with pravastatin in men with hypercholesterolemia, N. Engl. J. Med. 333 (1995), 1301-1307.
10. F. Sachs, M. Pfeffer, L. Moye et al., The effect of pravastatin on coronary events after miocardial infarction in patients with average cholesterol levels, N. Engl. J. Med. 335 (1996), 1001-1009.
11. M. Martinez, A. Vaya, R. Marti, L. Gil, I. Lluch, R. Carmena and J. Aznar, Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin, Thromb. Res. 83 (1996), 375-388.
12. C. Vaughan, M. Murphy and B. Buckley, Statins do more than just lower cholesterol, Lancet 348 (1996), 1079-1082.
13. F. Jung, G. Pindur and H. Kiesewetter, Plasma viscosity dependence on proteins and lipoproteins: Results of The Aachen-Study, Clin. Hemorheol. 12 (1992), 557-571.
14. D. Eterovic, I. Pintaric, J. Tocily and Z. Reiner, Determinants of plasma viscosity in primary hyperlipoproteinemias, Clin. Hemorheol. 15 (1995), 841-850.
15. M. Litt, R.E. Korn and S.E. Litt, Theory and design of disposable clinical blood viscometer, Biorheology 25 (1988), 697-712.
16. O.K. Baskurt and H.J. Meiselman, Cellular determinants of low-shear blood viscosity, Biorheology 34 (1997), 235-247.
17. L. Dintenfass, Red cell rigidity, "Tk", and filtration, Clin. Hemorheol. 5 (1985), 241-244.
18. W. Friedewald, R. Levy and D. Fredrickson, Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge, Clin. Chem. 18 (1972), 499.
19. J. Herd et al., The effect of Fluvastatin on aterosclerosis, The Lipoprotein and Coronary Aterosclerosis Study (LCAS), Circulation 94 (Suppl. P) (1996), 1-5.
20. M. Ercan, D. Konukolu, T. Erdem and S. Onen, The effects of cholesterol levels on hemorheological parameters in diabetic patients, Clin. Hemorheol. Microcirc. 26 (2002), 257-263.
21. F. Minano, E. Zamora, C. Holgado et al., Altered phospholipidic composition of erythrocyte membrane in hypercholesterolemias; Reason for rheological-abnormalities, Atherosclerosis 115 (1995), 109.
22. E. Hessel, J.J. Agren, M. Paulitchke et al., Freshwater fish diet affects lipid composition, deformability and aggregation properties of erythrocytes, Atherosclerosis 82 (1990), 37-42.
23. I. Cicha, Y. Suzuki, N. Tateishi and N. Maeda, Enhancement of red cell aggregation by plasma triglycerides, Clin. Hemorheol. Microcirc. 24 (2001), 247-255.
24. K. Cefle, S. Tarmer, A. Kaymaz et al., The effect of atorvastatin on hemorheological parameters in rabbits fed on a normal diet, Clin. Hemorheol. Microcirc. 26 (2002), 265-271.
25. B. Alberts, D. Bray, J. Lewis et al., Molecular Biology of the Cell, Vol. 2, Garland Publishing. Inc., New York, London, 1983, 312p.
26. T. Nakano, Y. Wada and S. Matsumura, Membrane lipid components associated with increased filterability of erythrocytes from long-distance runners, Clin. Hemorheol. Microcirc. 24 (2001), 85-92.
27. P. Kanakaraj and M. Singth, Influence of hypercholesterolemia on morphological and rheological characteristics of erythrocytes, Atherosclerosis 76 (1989), 209-218.
28. O. Abugo, R. Peddada, J. Kelly, G. Roth and J. Rifkind, Effect of cholesterol content in diet on capillary flow of rat erythrocytes. Part I: Geometric and flow characteristics, Clin. Hemorheol. Microcirc. 17 (1997), 437-443.
29. Y. Lange and J.M.M. Slayton, Interaction of cholesterol and lysophosphatidyl choline in determining red cell shape, J. Lipid Res. 23 (1982), 1121-1127.
30. T. Fujii and A. Tamura, Dynamic behavior of amphiphilic lipids to penetrate into the membrane of intact human erythrocytes and to induce change in the cell shape, Biomed. Biochim. Acta 42 (1983), S81-S85.
31. C. Bruneau, D. Laustriat, V. Camberlein, G. Cremel and M.L. North, Effects of two cholesterol derivatives on erythrocytes deformability and membrane fluidity on intact red blood cells and ghosts, Clin. Hemorheol. 11 (1991), 583-595.
32. F. Pinon, J.F. Merino, J.C. Ferrer et al., Plasma lipids and blood fluidity in parients with polygenic hypercholesterolemia treated with fluvastatin, Clin. Hemorheol. Microcirc. 27 (2002), 193-200.